Search

Search Results
Results 81971 - 81980 of 83251 for cancer
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Tysabri intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Zypine and Zypine ODT (olanzapine) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Meloxicam Viatris (Meloxicam) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Maxor intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Maxor Heartburn Relief intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Eferas intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Cilatil intended for persons living in Australia.
  • Health - 22 Jan 2024
    Digital pathology is a digital image-based practice of pathology.
  • Health - 19 Jan 2024
    Functional gastrointestinal disorders (FGID) are common disorders associated with persistent and recurrent gastrointestinal (GI) symptoms. Several studies have indicated that stress and psychological...
  • White Paper - 10 Jan 2024
    This article from Merck outlines poly(ethylene glycol) (PEG) and synthetic PEG derivatives and how they're used for tissue engineering and cell delivery.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.